Skip to main content

  • Excessive Underarm Sweat
    • Are You Sweat Bothered?
    • Excessive Underarm Sweating
    • Why our Underarms Sweat
    • Additional Sweating Resources
  • miraDry Solution
    • What is miraDry?
    • miraDry Procedure
    • FAQs
    • Request Information
  • Patient Stories
    • Share Your Story
  • Find a Physician

   

Visit Physician Site

You are here

Home » In The News

Miramar Labs

  • About Miramar Labs
  • Board of Directors
  • Management Team
  • Advisory Board
  • Investors
  • Press Releases
  • Careers
  • Contact Us

We appreciate your feedback. Tell us about your visit.

Click Here

 

Press Releases

Nov 2012:

Miramar Labs Announces Health Canada Regulatory Approval for the miraDry® System to Treat Excessive Underarm Sweat

Oct 2012:

Lasting Sweat Reduction Sustained for Two Years in Patients with Axillary Hyperhidrosis

Sept 2012:

Miramar Labs Announces South Korean Regulatory Approval for the miraDry® System to Treat Excessive Underarm Sweat

Jan 2012:

Miramar Labs Launches miraDry System to Treat Excessive Underarm Sweat

Dec 2011:

Miramar Labs appoints Brigid Makes as Senior Vice President and Chief Financial Officer

July 2011:

Miramar Labs Secures $35 Million in Series C Financing for Commercialization

Feb 2011:

miraDry by Miramar Labs Receives FDA 510(k) Clearance


 

Media Inquiries

For all media inquiries please contact

Jennifer Chan
Tel: 415-229-7650
jennifer.chan@edelman.com

About Miramar Labs

Board of Directors
Management Team

Advisory Board
Investors
Press Releases

Careers
Contact Us
miraDry.com Survey Winner

For Physicians

miraDry System
How miraDry Works
miraDry Procedure

Clinical Studies & Publications
Events
News

Customer's Resource (MIC)

Patient Stories & News

Patient Stories
In The News

Join Our Community

 

 

 
Japan site

Miramarlabs small logo© 2009-2012 Miramar Labs, Inc. All rights reserved. Miramar Labs® and miraDry® are registered trademarks of Miramar Labs, Inc. miraWave™ is a trademark of Miramar Labs, Inc.

Legal Policy | Sitemap